Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Cordis reports positive trial results for its SELUTION SLR balloon, showing reduced reblockage in peripheral artery disease patients.
Cordis reported positive results from two clinical trials of its SELUTION SLR drug-eluting balloon, showing improved outcomes in patients with peripheral artery disease, including reduced rates of target lesion revascularization and restenosis.
The findings were presented at a medical conference and support the device’s potential to enhance long-term vascular patency.
5 Articles
Cordis informa resultados positivos de ensayos para su globo SELUTION SLR, que muestran una reducción de la reobstrucción en pacientes con enfermedad arterial periférica.